These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 18723350)

  • 1. Development of novel tail-modified anandamide analogs.
    Yao F; Li C; Vadivel SK; Bowman AL; Makriyannis A
    Bioorg Med Chem Lett; 2008 Nov; 18(22):5912-5. PubMed ID: 18723350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, binding studies and molecular modeling of novel cannabinoid receptor ligands.
    Osman NA; Mahmoud AH; Allarà M; Niess R; Abouzid KA; Di Marzo V; Abadi AH
    Bioorg Med Chem; 2010 Dec; 18(24):8463-77. PubMed ID: 21074998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and pharmacological evaluation of sulfamide-based analogues of anandamide.
    Cano C; Páez JA; Goya P; Serrano A; Pavón J; Rodríguez de Fonseca F; Suardíaz M; Martín MI
    Eur J Med Chem; 2009 Dec; 44(12):4889-95. PubMed ID: 19762126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New resorcinol-anandamide "hybrids" as potent cannabinoid receptor ligands endowed with antinociceptive activity in vivo.
    Brizzi A; Brizzi V; Cascio MG; Corelli F; Guida F; Ligresti A; Maione S; Martinelli A; Pasquini S; Tuccinardi T; Di Marzo V
    J Med Chem; 2009 Apr; 52(8):2506-14. PubMed ID: 19331413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid CB1 and CB2 receptor ligand specificity and the development of CB2-selective agonists.
    Ashton JC; Wright JL; McPartland JM; Tyndall JD
    Curr Med Chem; 2008; 15(14):1428-43. PubMed ID: 18537620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel analogues of arachidonylethanolamide (anandamide): affinities for the CB1 and CB2 cannabinoid receptors and metabolic stability.
    Lin S; Khanolkar AD; Fan P; Goutopoulos A; Qin C; Papahadjis D; Makriyannis A
    J Med Chem; 1998 Dec; 41(27):5353-61. PubMed ID: 9876105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of endocannabinoid-based chemical probes for the study of cannabinoid receptors.
    Martín-Couce L; Martín-Fontecha M; Capolicchio S; López-Rodríguez ML; Ortega-Gutiérrez S
    J Med Chem; 2011 Jul; 54(14):5265-9. PubMed ID: 21675776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anandamide membrane transporter. Structure-activity relationships of anandamide and oleoylethanolamine analogs with phenyl rings in the polar head group region.
    Di Marzo V; Ligresti A; Morera E; Nalli M; Ortar G
    Bioorg Med Chem; 2004 Oct; 12(19):5161-9. PubMed ID: 15351399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical synthesis, pharmacological characterization, and possible formation in unicellular fungi of 3-hydroxy-anandamide.
    De Petrocellis L; Deva R; Mainieri F; Schaefer M; Bisogno T; Ciccoli R; Ligresti A; Hill K; Nigam S; Appendino G; Di Marzo V
    J Lipid Res; 2009 Apr; 50(4):658-66. PubMed ID: 19017617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel, potent THC/anandamide (hybrid) analogs.
    Bourne C; Roy S; Wiley JL; Martin BR; Thomas BF; Mahadevan A; Razdan RK
    Bioorg Med Chem; 2007 Dec; 15(24):7850-64. PubMed ID: 17827022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CB1 and CB2 cannabinoid receptor agonists induce peripheral antinociception by activation of the endogenous noradrenergic system.
    Romero TR; Resende LC; Guzzo LS; Duarte ID
    Anesth Analg; 2013 Feb; 116(2):463-72. PubMed ID: 23302980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anandamide-mediated CB1/CB2 cannabinoid receptor--independent nitric oxide production in rabbit aortic endothelial cells.
    McCollum L; Howlett AC; Mukhopadhyay S
    J Pharmacol Exp Ther; 2007 Jun; 321(3):930-7. PubMed ID: 17379772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling of ligand binding to G protein coupled receptors: cannabinoid CB1, CB2 and adrenergic β 2 AR.
    Latek D; Kolinski M; Ghoshdastider U; Debinski A; Bombolewski R; Plazinska A; Jozwiak K; Filipek S
    J Mol Model; 2011 Sep; 17(9):2353-66. PubMed ID: 21365223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4-Aminocyclopentane-1,3-diols as platforms for diversity: synthesis of anandamide analogs.
    Zohrabi-Kalantari V; Jarrahian A; Bissantz C; Bergstrom DE; Barker EL; Link A
    Med Chem; 2013 Sep; 9(6):881-8. PubMed ID: 23157226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural and synthetic endocannabinoids and their structure-activity relationships.
    Palmer SL; Khanolkar AD; Makriyannis A
    Curr Pharm Des; 2000 Sep; 6(13):1381-97. PubMed ID: 10903399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of (13S)-methyl-substituted arachidonic acid analogues: templates for novel endocannabinoids.
    Papahatjis DP; Nahmias VR; Nikas SP; Schimpgen M; Makriyannis A
    Chemistry; 2010 Apr; 16(13):4091-9. PubMed ID: 20187040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor.
    Porter AC; Sauer JM; Knierman MD; Becker GW; Berna MJ; Bao J; Nomikos GG; Carter P; Bymaster FP; Leese AB; Felder CC
    J Pharmacol Exp Ther; 2002 Jun; 301(3):1020-4. PubMed ID: 12023533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural requirements for arachidonylethanolamide interaction with CB1 and CB2 cannabinoid receptors: pharmacology of the carbonyl and ethanolamide groups.
    Berglund BA; Boring DL; Wilken GH; Makriyannis A; Howlett AC; Lin S
    Prostaglandins Leukot Essent Fatty Acids; 1998 Aug; 59(2):111-8. PubMed ID: 9774174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Pyridone-Based Derivatives as Cannabinoid Receptor Type 2 Agonists.
    Faúndez-Parraguez M; Alarcón-Miranda C; Cho YH; Pessoa-Mahana H; Gallardo-Garrido C; Chung H; Faúndez M; Pessoa-Mahana D
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probable involvement of Ca(2+)-activated Cl(-) channels (CaCCs) in the activation of CB1 cannabinoid receptors.
    Romero TR; Pacheco Dda F; Duarte ID
    Life Sci; 2013 May; 92(14-16):815-20. PubMed ID: 23123446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.